Abbott Gets FDA Clearance to Develop New Test for Measuring Vitamin D Levels

In vitro diagnostics firm Abbott (Abbott Park, IL) says it has received FDA clearance to develop a fully automated test for measuring vitamin D levels in patients.

In vitro diagnostics firm Abbott (Abbott Park, IL) says it has received FDA clearance to develop a fully automated test for measuring vitamin D levels in patients. The test measures 25-hydroxyvitamin D (25-OH vitamin D) and uses the company’s ARCHITECT laboratory testing platform.

“The new ARCHITECT 25-OH vitamin D assay has shown excellent precision and offers a fully automated solution that may help laboratories cope with escalating demand for vitamin D testing and help get results to physicians and their patients much sooner,” stated Brian Blaser, senior vice president, diagnostics, Abbott, in a press release.

The company says that with a simple blood test, the ARCHITECT 25-OH vitamin D assay can measure 25-OH vitamin D, the stable and easily measured form of vitamin D, which converts into the active form of the vitamin in the body and helps regulate calcium and phosphate levels.